Open access · CC-BY
via OpenAlex
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders
GustavoR Morel, Priscila Chiavellini, Martina Canatelli-Mallat, Marianne Lehmann, Rodolfo G. Goya
Neural Regeneration Research · 2021 · ▲ 24 citations
Abstract
Hippocampus serves as a pivotal role in cognitive and emotional processes, as well as in the regulation of the hypothalamus-pituitary axis. It is known to undergo mild neurodegenerative changes during normal aging and severe atrophy in Alzheimer's disease. Furthermore, dysregulation in the hippocampal function leads to epilepsy and mood disorders. In the first section, we summarized the most salient knowledge on the role of glial cell-line-derived neurotrophic factor and its receptors focused on aging, cognition and neurodegenerative and hippocampal-related neurological diseases mentioned above. In the second section, we reviewed the therapeutic approaches, particularly gene therapy, using glial cell-line-derived neurotrophic factor or its gene, as a key molecule in the development of neurological disorders. In the third section, we pointed at the potential of regenerative medicine, as an emerging and less explored strategy for the treatment of hippocampal disorders. We briefly reviewed the use of partial reprogramming(definition) to restore brain functions, non-neuronal cell reprogramming to generate neural stem cells, and neural progenitor cells as source-specific neuronal types to be implanted in animal models of specific neurodegenerative disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4103/1673-5374.320966
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Morel, G., Chiavellini, P., Canatelli-Mallat, M., Lehmann, M., & Goya, R.G. (2021). Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders. <em>Neural Regeneration Research</em>. https://doi.org/10.4103/1673-5374.320966
Vancouver
Morel G, Chiavellini P, Canatelli-Mallat M, Lehmann M, Goya RG. Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders. Neural Regeneration Research. 2021. doi:10.4103/1673-5374.320966.
BibTeX
@article{gustavor2021Therap,
title = {Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders},
author = {GustavoR Morel and Priscila Chiavellini and Martina Canatelli-Mallat and Marianne Lehmann and Rodolfo G. Goya},
journal = {Neural Regeneration Research},
year = {2021},
doi = {10.4103/1673-5374.320966},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of rhinology 2025
Open access · CC-BY
Stem Cell Niches for Olfactory Regeneration and Their Therapeutic Applications
eScholarship (California Digital Library) 2019
Preprint · OA
Partial Reprogramming: A Shortcut to Rejuvenation
Biomaterials Research 2023
Open access · CC-BY
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
HORMONES 2008
Open access · OA
Autophagy in aging and in neurodegenerative disorders
Advanced Healthcare Materials 2025
Open access · CC-BY
Aging on Chip: Harnessing the Potential of Microfluidic Technologies in Aging and Rejuvenation Research
Annals of Neurology 2001
Citation only